|9.75||-0.35 / -3.47%|
Data as of 4:00pm ET
|9.75||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 26.00 and a low estimate of 10.00. The median estimate represents a +84.62% increase from the last price of 9.75.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.